Abstract
BackgroundThe management of enteric fever through antibiotics is difficult these days due to the emerging resistance of Salmonella to various antimicrobial agents. The development of antimicrobial resistance is associated with multiple factors including mutations in the specific genes. To know the current status of mutation-mediated fluoroquinolone-resistance among Salmonella enterica serovars; Typhi, Paratyphi A, B and C, this study was focused on detecting gyrA ser83 mutation by restriction digestion analysis of gyrA gene using HinfI endonuclease.ResultsA total of 948 blood samples were processed for isolation of Salmonella spp. and 3.4% of them were found to be positive for Salmonella growth. Out of the 32 Salmonella isolates, 2.2% were S. Typhi and 1.2% were S. Paratyphi A. More interestingly, we observed less than 5% of isolates were resistant to first-line drugs including chloramphenicol, cotrimoxazole and ampicillin. More than 80% of isolates were resistant to fluoroquinolones accounting for 84.4% to levofloxacin followed by 87.5% to ofloxacin and 100% to ciprofloxacin by disc diffusion methods. However, the minimum inhibitory concentration method using agar dilution showed only 50% of isolates were resistant to ciprofloxacin. A total of 3.1% of isolates were multidrug-resistant. Similarly, 90.6% of the Salmonella isolates showed gyrA ser83 mutation with resistance to nalidixic acid.ConclusionsThe increased resistance to fluoroquinolones and nalidixic acid in Salmonella isolates in our study suggests the use of alternative drugs as empirical treatment. Rather, the treatment should focus on prescribing first-line antibiotics since we observed less than 5% of Salmonella isolates were resistant to these drugs.
Highlights
The management of enteric fever through antibiotics is difficult these days due to the emerging resistance of Salmonella to various antimicrobial agents
17 (1.8%) samples were positive for Staphylococcus aureus, 20 (2.1%) for Coagulase Negative Staphylococci (CONS) and 7 (0.7%) were positive for Escherichia coli
Distribution of enteric fever cases based on the age of the patients The highest rate of Salmonella was isolated from blood specimens of the age groups 5–20 years (1.6%; 15/945) and 21–35 years (1.6%; 15/945) followed by 36–50 age group (0.2%; 2/945 (p < 0.0001) (Table 1)
Summary
The management of enteric fever through antibiotics is difficult these days due to the emerging resistance of Salmonella to various antimicrobial agents. To know the current status of mutation-mediated fluoroquinolone-resistance among Salmonella enterica serovars; Typhi, Paratyphi A, B and C, this study was focused on detecting gyrA ser mutation by restriction digestion analysis of gyrA gene using HinfI endonuclease. Enteric fever is an acute, life-threatening febrile infection caused by Salmonella enterica serovars; Typhi, Paratyphi A, B and C. Symptoms may vary from mild to severe and usually begin 6 to 30 days after exposure [1]. These isolates are highly adapted infections to the human population, having no animal and environmental reservoirs. As per the annual report published by the Department of Health Service (DoHS), Ministry of Health and Population, Nepal, enteric fever was still one of the top ten causes for inpatient morbidity (8.48%) [3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.